SCHEDULE: UBS Group AG Discloses 8.7% Stake in Clorox Co.
Shareholding Disclosure
UBS Group AG reports beneficial ownership of 10,794,027 shares of Clorox Co., representing an 8.7% stake.
Summary
- UBS Group AG, through its asset management division, has filed a Schedule 13G disclosing its ownership in Clorox Co.
- The filing indicates that UBS beneficially owns 10,794,027 shares of Clorox common stock.
- This represents approximately 8.7% of the outstanding shares of Clorox.
- UBS has sole voting power over 616,810 shares and shared dispositive power over 10,794,027 shares.
- The shares are held by various accounts managed by UBS Asset Management on a discretionary basis.
- No single account managed by UBS holds more than 5% of Clorox's outstanding shares.
Sentiment
Score: 7
Explanation: The document is a neutral disclosure of a significant shareholding, which is generally viewed positively as it indicates institutional confidence. However, it does not contain any specific positive or negative outlook.
Positives
- The disclosure indicates a significant investment by a major financial institution in Clorox.
- The large stake could suggest confidence in Clorox's future performance.
Risks
- The filing does not indicate any intention to influence the control of Clorox.
- The large stake could potentially lead to increased scrutiny from other investors.
Industry Context
This filing is a routine disclosure of a significant shareholding by a major financial institution. It is common for large asset managers like UBS to hold substantial positions in publicly traded companies.
Comparison to Industry Standards
- Large institutional investors like BlackRock, Vanguard, and State Street often hold similar stakes in major consumer goods companies.
- An 8.7% stake is a significant but not unusual holding for a large asset manager.
- The filing is consistent with standard regulatory requirements for disclosing beneficial ownership.
Stakeholder Impact
- The disclosure may increase investor confidence in Clorox.
- The large stake could potentially influence future corporate decisions.
Key Dates
| Date | Description |
|---|---|
| 12/31/2024 | Date of event which requires filing of this statement. |
| 01/24/2025 | Date of signature of the filing. |
Keywords
UBS, Clorox, shareholding, beneficial ownership, Schedule 13G, asset management, investment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.